![]()
MIRA INFORM REPORT
|
Report Date : |
25.07.2011 |
IDENTIFICATION DETAILS
|
Name : |
UNIVERSAL INTEGRATED CORP. |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
07.08.1986 |
|
|
|
|
Com. Reg. No.: |
22180049 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Wholesale of medicine and health related products, beauty
products, etc. |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 150,000 |
|
Status : |
Moderate |
|
Payment
Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Taiwan |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
|
|
Supplied Address: |
5FL, 129 FU Hsing South Rd Section 1 TA-AN Dist Taipei City, 106,
Taiwan |
|
Telephone Number: |
|
|
Fax Number: |
Notes:
The exact address
is as above.
|
Credit Rating: |
|
|
Credit Opinion: |
Subject was incorporated on
|
Subscription
Number |
|
|
Xiejun
Qiu |
975,000 |
|
Shenxia Song |
|
|
770,600 |
|
|
Weizhong
Qiu |
237,200 |
|
Weiqun
Qiu |
237,077 |
The information above is that of subject’s
major shareholders.
Core Management
|
1 |
|
|
Name |
Xiejun Qiu |
|
Position |
Board Chairman |
|
2 |
|
|
Name |
Shenxia Song |
|
Position |
Director |
|
3 |
|
|
Name |
Weizhong Qiu |
|
Position |
Director |
|
4 |
|
|
Name |
Weiqun Qiu |
|
Position |
Supervisor |
Personnel Structure
|
Total Employees |
About 150 Employees |
Offices & Factories
|
|
Headquarters
|
|
Add |
|
Production Information
l
Subject
is a trader of medicine and health related
products, beauty products etc without any production activities
Purchase Information
l
The
registered activities of subject:
|
Business Code |
Details
|
|
F108011 |
Wholesale
of Traditional Chinese medicine |
|
F108021 |
Wholesale
of Western medicine |
|
F208011 |
Retail
of Traditional Chinese medicine |
|
F208021 |
Retail
of Western medicine |
|
F108040 |
Wholesale
of Cosmetic |
|
F208040 |
Retail
of Cosmetic |
|
F102170 |
Wholesale
of Food And Beverage |
|
F203010 |
Retail of
Food And Beverage |
|
F102040 |
Wholesale
of Beverage |
|
F401010 |
International
Trading |
|
F107080 |
Retail
of Environmental agents |
|
J303010 |
Magazine
Industry |
|
J305010 |
Audio
Publishing Industry |
|
E701010 |
Communications
Engineering |
|
ZZ99999 |
Besides
licensed business, all other business items those are not banned or
restricted. |
l
Subject
is mainly involved in wholesaling of medicine
and health related products, beauty products, etc. And it also importing
& marketing Superior
healthcare products in Taiwan
l
Subject
imports from many countries, such as Europe, USA, and Japan.
l
Subject
is the agency of Xanthium, Erispan, Salagen, Fleet(PHOSPHO-SODA), (Summers
Eve), FlexNow
l
The
clients of the subject are mostly hospitals, clinics, Waston, supermarkets.
Import and export right:
|
Import
right |
Yes |
|
Export
right |
Yes |
Purchase
Subject declined to
disclose any information on the purchase settlements.
Sales
Domestic
Markets (Taiwan)
|
Sales
Terms |
Proportion |
|
|
Medicine
and health related products, beauty products |
COD,
etc |
100% |
Export
Subject seldom
exports to foreign markets.
Subject has no obligations
to disclose its financial statements to the third party according to the
relevant policy in Taiwan and the only source from which we can obtain the
information is the subject itself.
Subject’s relevant
staff Ms. Guo declined to disclose its financials citing the grounds of
company’s confidentiality; from other source we can not obtain the relevant
information, either.
Subject declined to
disclose any information on Bankers, and we couldn’t obtain the information
from other sources.
Mortgage
No chattel mortgage
record of subject has been found within the recent 3 months.
Lawsuit
|
97,北簡,4482 |
|
|
Trial Date: |
|
|
Trial Cause Of
Action |
COB |
|
Name |
Ms. Guo |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.38 |
|
UK Pound |
1 |
Rs.72.34 |
|
Euro |
1 |
Rs.63.87 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.